In the case of GL26 glioma tumors, T+H treatment triggered ~20–50% increase in CD4+ T cell infiltration, compared to TMZ or HOE642 monotherapy alone (Supplemental Figure 7). The gene discussed is CD4; the disease is central nervous system cancer.